VAFSEO (Adjutor Healthcare Pty Ltd)
Product name
VAFSEO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
244 (255 working days
Active ingredients
vadadustat
Registration type
NCE/NBE
Indication
Vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (CKD) in adults on chronic maintenance dialysis.